News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 10, 2016, 06:00 ET United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Jul 28, 2016, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2016 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2016. "We are...


Jul 21, 2016, 06:00 ET United Therapeutics Corporation To Announce Second Quarter 2016 Financial Results Before The Market Opens On Thursday, July 28, 2016

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2016 financial results before the market...


Apr 28, 2016, 06:05 ET United Therapeutics Corporation Announces Executive Leadership Changes

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D. has stepped down as the company's President and...


Apr 28, 2016, 06:00 ET United Therapeutics Corporation Reports First Quarter 2016 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2016. "Our...


Apr 27, 2016, 06:00 ET United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, of...


Apr 20, 2016, 06:00 ET United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2016 financial results before market...


Mar 08, 2016, 06:00 ET United Therapeutics Corporation To Present At Barclays Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


Feb 25, 2016, 06:00 ET United Therapeutics Corporation Reports 2015 Fourth Quarter And Annual Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31,...


Feb 18, 2016, 20:30 ET United Therapeutics Corporation To Announce Fourth Quarter And Annual 2015 Financial Results Before Market Open On Thursday, February 25, 2016

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2015 financial results...


Feb 18, 2016, 20:00 ET United Therapeutics Receives Paragraph IV Notice Letter For Orenitram

 United Therapeutics Corporation (NASDAQ: UTHR) announced receipt of a Paragraph IV Certification Notice Letter on February 18, 2016 from...


Jan 06, 2016, 06:00 ET United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United...


Sep 30, 2015, 06:00 ET United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz Inc. ("Sandoz")...


Aug 19, 2015, 06:00 ET United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease...


Aug 17, 2015, 06:00 ET European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for...


Aug 06, 2015, 06:00 ET United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...


Jun 29, 2015, 06:00 ET Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors

 United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an...


Jun 15, 2015, 09:00 ET United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

 United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories,...


May 29, 2015, 06:00 ET United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


May 21, 2015, 09:31 ET Critical Alerts For United Therapeutics Corporation, Yahoo!, Chesapeake Energy, Clean Energy Fuels and CyberArk Software Released By InvestorsObserver

 InvestorsObserver issues critical PriceWatch Alerts for UTHR, YHOO, CHK, CLNE and CYBR. To see what our analysts have discovered about a...


May 01, 2015, 06:00 ET United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


Apr 28, 2015, 06:00 ET United Therapeutics Corporation Reports First Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total...


Apr 21, 2015, 06:00 ET United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on...


Mar 10, 2015, 11:18 ET United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin™ for Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics...


Mar 10, 2015, 11:12 ET FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...